Clinical Trials Browser

Recruiting × Osteosarcoma × Irinotecan × Clear all

NCT06541262 2026-03-02

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

Phase 1/2 Recruiting

Liposarcoma, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma

NCT05400603 2025-12-26

Aflac-NBL-2002

Phase 1 Recruiting

Neuroblastoma, Osteosarcoma